Literature DB >> 12852841

Pharmacokinetics of loratadine and its active metabolite descarboethoxyloratadine in healthy Chinese subjects.

Yi-Fan Zhang1, Xiao-Yan Chen, Da-Fang Zhong, Yu-Mei Dong.   

Abstract

AIM: To investigate the pharmacokinetics of loratadine (LOR) and its active metabolite descarboethoxyloratadine (DCL) in healthy Chinese subjects.
METHODS: Twenty healthy Chinese male subjects received a single oral dose of LOR 20 mg. A sensitive liquid chromatography-tandem mass spectrometry method (LC/MS/MS) was used for the determination of LOR and DCL in plasma.
RESULTS: Mean maximum concentration (C(max)) was found (17+/-14) microg/L for LOR at 1.2 h and (16+/-9) microg/L for DCL at 1.5 h. Mean area under the plasma concentration-time curve from zero to infinity (AUC(0-infinity)) was (47+/-49) microg x h x L(-1) for LOR and (181+/-122) microg x h x L(-1) for DCL, respectively. The apparent elimination half-life (T1/2) of LOR was (6+/-4) h, and that of DCL was (13.4+/-2.6) h. The ratios of AUC(DCL)/AUCLOR ranged from 0.36 to 54.5.
CONCLUSION: LOR was rapidly absorbed and transformed to DCL. AUC of the parent drug was extremely variable, while AUC of the active metabolite DCL was moderately variable after an oral dose of LOR to Chinese subjects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12852841

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  5 in total

1.  Combined blockade of the histamine H1 and H4 receptor suppresses peanut-induced intestinal anaphylaxis by regulating dendritic cell function.

Authors:  M Wang; J Han; J Domenico; Y S Shin; Y Jia; E W Gelfand
Journal:  Allergy       Date:  2016-08-03       Impact factor: 13.146

2.  The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers.

Authors:  Lene Noehr-Jensen; Per Damkier; Tanja Busk Bidstrup; Rasmus Steen Pedersen; Flemming Nielsen; Kim Brosen
Journal:  Eur J Clin Pharmacol       Date:  2006-04-28       Impact factor: 2.953

Review 3.  Second-generation antihistamines: actions and efficacy in the management of allergic disorders.

Authors:  Larry K Golightly; Leon S Greos
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Chemical Probes for Histamine Receptor Subtypes.

Authors:  Markus Falkenstein; Milica Elek; Holger Stark
Journal:  Curr Top Behav Neurosci       Date:  2022

5.  A new evaluation method for +Gz tolerance with loratadine by using a near-infrared spectroscopy.

Authors:  Akihiko Onozawa; Azusa Kikukawa; Yoshinori Miyamoto
Journal:  Dyn Med       Date:  2008-01-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.